0001209191-21-049157.txt : 20210802
0001209191-21-049157.hdr.sgml : 20210802
20210802213028
ACCESSION NUMBER: 0001209191-21-049157
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210729
FILED AS OF DATE: 20210802
DATE AS OF CHANGE: 20210802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ho William Tai-Wei
CENTRAL INDEX KEY: 0001830914
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39692
FILM NUMBER: 211137638
MAIL ADDRESS:
STREET 1: C/O IN8BIO, INC.
STREET 2: 79 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IN8BIO, INC.
CENTRAL INDEX KEY: 0001740279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 825462585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 79 MADISON AVENUE, 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: (646) 600-6438
MAIL ADDRESS:
STREET 1: 79 MADISON AVENUE, 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Incysus Therapeutics, Inc.
DATE OF NAME CHANGE: 20180510
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-29
0
0001740279
IN8BIO, INC.
INAB
0001830914
Ho William Tai-Wei
C/O IN8BIO, INC.
79 MADISON AVENUE
NEW YORK
NY
10016
1
1
0
0
President, CEO and CFO
Employee Stock Option (right to buy)
10.00
2021-07-29
4
A
0
220500
0.00
A
2031-07-29
Common Stock
220500
220500
D
One forty-eighth (1/48th) of the shares subject to the option shall vest in equal monthly installments commencing on August 29, 2021, subject to the Reporting Person continuing to provide service through each such date.
/s/ Jason Minio, Attorney-in-Fact
2021-08-02